OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
METTL14/YTHDF1 axis-modified UCHL5 aggravates atherosclerosis by activating the NLRP3 inflammasome
Xiaohu Yang, Chen Wang, Guanglang Zhu, et al.
Experimental Cell Research (2023) Vol. 427, Iss. 2, pp. 113587-113587
Closed Access | Times Cited: 14
Xiaohu Yang, Chen Wang, Guanglang Zhu, et al.
Experimental Cell Research (2023) Vol. 427, Iss. 2, pp. 113587-113587
Closed Access | Times Cited: 14
Showing 14 citing articles:
WTAP participates in neuronal damage by protein translation of NLRP3 in an m6A-YTHDF1-dependent manner after traumatic brain injury
Yuhua Chen, Tianlin Long, Junhui Chen, et al.
International Journal of Surgery (2024) Vol. 110, Iss. 9, pp. 5396-5408
Open Access | Times Cited: 11
Yuhua Chen, Tianlin Long, Junhui Chen, et al.
International Journal of Surgery (2024) Vol. 110, Iss. 9, pp. 5396-5408
Open Access | Times Cited: 11
Heat stress enhances the expression of METTL3 to mediate N6-methyladenosine modification of SOS2 and NLRP3 inflammasome activation in boar Sertoli cells
Xuhua Zhang, Yan Lin Tang, Jinxuan Wang, et al.
Journal of Hazardous Materials (2025) Vol. 488, pp. 137432-137432
Closed Access
Xuhua Zhang, Yan Lin Tang, Jinxuan Wang, et al.
Journal of Hazardous Materials (2025) Vol. 488, pp. 137432-137432
Closed Access
Recent Advances in the Mutual Regulation of m6A Modification and Non-Coding RNAs in Atherosclerosis
Yanlu Wang, Shun M. Ling, Hao Feng, et al.
International Journal of General Medicine (2025) Vol. Volume 18, pp. 1047-1073
Open Access
Yanlu Wang, Shun M. Ling, Hao Feng, et al.
International Journal of General Medicine (2025) Vol. Volume 18, pp. 1047-1073
Open Access
Mechanisms and Therapeutic Strategies for NLRP3 Degradation via Post-Translational Modifications in Ubiquitin-proteasome and Autophagy Lysosomal Pathway
Kaiyue Su, Minghai Tang, Jie Wu, et al.
European Journal of Medicinal Chemistry (2025) Vol. 289, pp. 117476-117476
Closed Access
Kaiyue Su, Minghai Tang, Jie Wu, et al.
European Journal of Medicinal Chemistry (2025) Vol. 289, pp. 117476-117476
Closed Access
Exploring the efficacious subfractions and underlying mechanisms of Herba Siegesbeckiae against myocardial ischemia/reperfusion injury via the UCHL5/NLRP3 pathway
Xue-Fen Wu, Huan Xia, Wanting Li, et al.
Acta Materia Medica (2024) Vol. 3, Iss. 4
Open Access | Times Cited: 4
Xue-Fen Wu, Huan Xia, Wanting Li, et al.
Acta Materia Medica (2024) Vol. 3, Iss. 4
Open Access | Times Cited: 4
The roles of ubiquitination and deubiquitination of NLRP3 inflammasome in inflammation-related diseases: A review
Shaokai Tang, Yuanwen Geng, Yawei Wang, et al.
Biomolecules and Biomedicine (2024) Vol. 24, Iss. 4, pp. 708-721
Open Access | Times Cited: 3
Shaokai Tang, Yuanwen Geng, Yawei Wang, et al.
Biomolecules and Biomedicine (2024) Vol. 24, Iss. 4, pp. 708-721
Open Access | Times Cited: 3
The m6A demethylase ALKBH5 is a novel epigenetic regulator of aortic valve calcification
Yueheng Wang, Shengping He, Lan Lan, et al.
Cardiovascular Research (2024)
Closed Access | Times Cited: 1
Yueheng Wang, Shengping He, Lan Lan, et al.
Cardiovascular Research (2024)
Closed Access | Times Cited: 1
Unraveling the priming phase of NLRP3 inflammasome activation: Molecular insights and clinical relevance
Yonghong Liao, Yao Kong, Hongyu Chen, et al.
International Immunopharmacology (2024) Vol. 146, pp. 113821-113821
Open Access | Times Cited: 1
Yonghong Liao, Yao Kong, Hongyu Chen, et al.
International Immunopharmacology (2024) Vol. 146, pp. 113821-113821
Open Access | Times Cited: 1
N6-Methyladenosine in Vascular Aging and Related Diseases: Clinical Perspectives
Chen Li, Le Liu, Shuang Li, et al.
Aging and Disease (2023)
Open Access | Times Cited: 4
Chen Li, Le Liu, Shuang Li, et al.
Aging and Disease (2023)
Open Access | Times Cited: 4
m6A epitranscriptomic modification of inflammation in cardiovascular disease
Yun-Sen Zhang, Zhiyan Liu, Zhenyu Liu, et al.
International Immunopharmacology (2024) Vol. 134, pp. 112222-112222
Closed Access | Times Cited: 1
Yun-Sen Zhang, Zhiyan Liu, Zhenyu Liu, et al.
International Immunopharmacology (2024) Vol. 134, pp. 112222-112222
Closed Access | Times Cited: 1
N6-methyladenosine in inflammatory diseases: Important actors and regulatory targets
Zewen Li, Yongfeng Lao, Rui Yan, et al.
Gene (2024) Vol. 936, pp. 149125-149125
Closed Access | Times Cited: 1
Zewen Li, Yongfeng Lao, Rui Yan, et al.
Gene (2024) Vol. 936, pp. 149125-149125
Closed Access | Times Cited: 1
Levels and clinical significance of the m6A methyltransferase METTL14 in patients with coronary heart disease
Fengxia Guo, Mei He, Bing Hu, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 2
Fengxia Guo, Mei He, Bing Hu, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 2
Qingqing Tian, Juqing Huang, Qin Zhang, et al.
Clinical and Experimental Pharmacology and Physiology (2024) Vol. 51, Iss. 6
Closed Access
Mechanism of Si Ni San Combined with Astragalus in Treating Hepatic Fibrosis: A Network Pharmacology and Molecular Docking Study
Jiu Jin, Jiuwang Yu, Chenxu Zhai, et al.
Molecular Biotechnology (2024) Vol. 67, Iss. 3, pp. 1077-1094
Closed Access
Jiu Jin, Jiuwang Yu, Chenxu Zhai, et al.
Molecular Biotechnology (2024) Vol. 67, Iss. 3, pp. 1077-1094
Closed Access
